Update from ASCO: Annual Meeting of the American Society of Clinical Oncology
When: Wednesday, June 22, 2011
12:00 p.m. to 1:15 p.m. Eastern Daylight Time (EDT)
Our June teleconference speaker, Ruth O’Regan, MD, shared updates from the largest annual meeting of cancer doctors in the world. These include advances in treatment for early-stage and metastatic breast cancer, as well as new strategies for managing side effects and improving your quality of life. During this podcast, you will:
- Learn more about the aromatase inhibitor exemestane (Aromasin) and its role in primary prevention of breast cancer
- Hear about a study that suggests that some women with early breast cancer should be offered radiation treatment to their regional lymph nodes, in addition to standard whole-breast radiation
- Hear updates on treatment options for triple-negative breast cancer, HER2 positive breast cancer and metastatic breast cancer
- Explore new ways to cope with side effects
About Our Speaker
Dr. O’Regan is an associate professor of hematology and medical oncology and the director of the translational breast cancer research program at the Emory Winship Cancer Institute. Her research focuses on the differences in breast cancer subtypes in pre- and post-menopausal women and on triple-negative breast cancers in African-American women.
This program was sponsored by Amgen.